Keith Ward

Chief Executive Officer at

InterveXion Therapeutics LLC

56 year

Health Technology

Consumer Services

Profile

Keith W.
Ward is the founder of Kuria Therapeutics, Inc. (founded in 2022) and currently holds the position of President & Chief Executive Officer.
He is also the President & Chief Executive Officer at InterveXion Therapeutics LLC since 2019.
Dr. Ward has previously worked as the Director-Preclinical Drug Discovery at GlaxoSmithKline LLC.
He served as an Independent Director at Skye Bioscience, Inc. from 2021 to 2024.
From 2008 to 2011, he was the Global VP-Pharmaceutical Research & Development at Bausch & Lomb, Inc. Dr. Ward held the position of Chief Development Officer & Executive VP at Reata Pharmaceuticals, Inc. from 2011 to 2019.
He also served as the Chief Development Advisor at Unicycive Therapeutics, Inc. from 2020 to 2022.
Dr. Ward holds a doctorate degree from The University of North Carolina at Chapel Hill and an undergraduate degree from Northeast Louisiana University.

Keith Ward active positions

Companies	Position	Start
InterveXion Therapeutics LLC InterveXion Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops drugs and antibody-based therapies	Chief Executive Officer	01/01/2019
Kuria Therapeutics, Inc. Kuria Therapeutics, Inc. BiotechnologyHealth Technology Develops novel ophthalmic and dermal therapeutics	Chief Executive Officer	01/02/2022

All active positions of Keith Ward

Former positions of Keith Ward

Companies	Position	End
SKYE BIOSCIENCE, INC.	Director/Board Member	01/08/2024
UNICYCIVE THERAPEUTICS, INC.	Corporate Officer/Principal	01/07/2022
REATA PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/03/2019
Bausch & Lomb, Inc. Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies contact lenses	Corporate Officer/Principal	01/06/2011
GlaxoSmithKline LLC GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines	Corporate Officer/Principal	-

See the detail of Keith Ward's experience

Training of Keith Ward

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Keith Ward's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Bausch & Lomb, Inc. Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies contact lenses	Health Technology
Reata Pharmaceuticals, Inc. Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics which regulates cellular metabolism and inflammation in serious neurologic diseases	Health Technology
The University of North Carolina at Chapel Hill The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
InterveXion Therapeutics LLC InterveXion Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops drugs and antibody-based therapies	Health Technology
GlaxoSmithKline LLC GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines	Health Technology
Northeast Louisiana University Northeast Louisiana University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Skye Bioscience, Inc. Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders	Health Technology
Unicycive Therapeutics, Inc. Unicycive Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs to treat kidney diseases	Health Technology
Kuria Therapeutics, Inc. Kuria Therapeutics, Inc. BiotechnologyHealth Technology Develops novel ophthalmic and dermal therapeutics	Health Technology

See company connections